[ ]
Anne Arundel Medical Center

Neighbors News


Neighbors News

Breaking Health News, March 10, 2004

Cholesterol Study Finds Reasons For Intensive Therapy

"Profound" Implications To Challenge Current Cholesterol Recommendations

< March 10, 2004 > -- Aggressive treatment with cholesterol-lowering medications can dramatically lower heart disease risk and save lives, according to a major study presented at the American College of Cardiology meeting in New Orleans and published in the New England Journal of Medicine (NEJM).Picture of a man standing and smiling

New research shows high levels of medications called statins, given to people who have just been hospitalized with heart attacks or high-risk unstable angina, not only saved lives but also helped prevent future problems.

Currently, statins are considered a major componet of the standard of care for heart disease prevention and treatment of heart attack.

Researchers Find Conclusive Evidence

The new research findings suggest that higher doses of statins than are currently prescribed will lead to a better outcome for patients.

"The implications of this turning point - that is, of the new era of intensive statin therapy - are profound," says Dr. Eric Topol, chairman of the department of cardiovascular medicine at the Cleveland Clinic Foundation and author of an editorial in the NEJM.

Current guidelines from the National Cholesterol Education Program state that levels of LDL cholesterol, the kind referred to as the "bad" cholesterol, should reach 100 milligrams/per deciliter (mg/dL) or below. But the new study has definitively found that lowering this number considerably, by more than one-third below 100 mg/dL was very beneficial.

"This will have a major impact in the real world," says Dr. Topol. "It was striking how fast it was. It was a whopping benefit and unexpected. This changes everything."

Dr. Christopher P. Cannon, co-author of the study and a cardiologist at Brigham and Women's Hospital in Boston, says, "The basis of our study was that statins were tested and were very, very effective. But the drugs had not yet been tested in a hospital setting in people who were seriously ill."

The current study set out to answer two questions, Dr. Cannon says.

The first was whether statins would be effective in heart attack patients in a hospital setting. The second, and bigger question, was whether it would be worth it to lower cholesterol levels by 50 percent, instead of the 25 percent already demonstrated.

The trial involved 4,162 patients at 349 sites in eight countries. All of the participants had been hospitalized within the past 10 days with either a heart attack or high-risk, unstable angina.

The study compared 40 mg daily of pravastatin (PravacholTM) to 80 mg daily of atorvastatin (LipitorTM). These doses were the highest approved doses at the time of the study.

Patients who were given Lipitor reduced their LDL to an average of 62 mg/dL compared to those given Pravachol with an average of 95 mg/dL.

Over a period of about 24 months, the Lipitor group showed a 16 percent lower risk of overall major cardiovascular events and a 28 percent reduction in death.

Every outcome measured was better in the Lipitor group, except for stroke, which was about the same in both groups.

The downside of this more intensive treatment is minimal, Dr. Cannon adds.

"We have to be a little cautious on the liver," he says. About 1 percent of the control group and 3 percent of the intensive therapy group experienced liver problems.

More People Need This Therapy, Experts Say

Dr. Cannon says, "Hopefully the very clear results will mean that people going home from the hospital will get this treatment."

Currently, says Dr. Topol, "Only a fraction of the patients who should be treated with a statin are actually receiving such therapy." He reports that about 11 million US adults are getting statins when an estimated 36 million should be on them.

This is largely a cost issue, Dr. Topol states. At a collective $12.5 billion, statins are the largest prescription drug expenditure in the US, he writes.

"Treatment based on the new data could cause the costs associated with statin therapy to skyrocket even further," Dr. Topol says.

Always consult your physician for more information.

Online Resources

(These links are provided for the education and convenience of our Neighbors. AAMC is not responsible for the content of Internet sites.)

American Heart Association

Centers for Disease Control and Prevention (CDC)

HealthierUS.Gov

National Cholesterol Education Program

National Heart, Lung, and Blood Institute

National Institutes of Health (NIH)

National Library of Medicine

US Food and Drug Administration

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter AAMC Neighbors News
For Email Marketing you can trust

picture of Joint Commission Logo

Anne Arundel Medical Center is a private non-profit hospital serving Maryland.

Anne Arundel Medical Center is an Equal Opportunity Health Care Provider.
2001 Medical Parkway, Annapolis Maryland 21401  (443) 481-1000
askAAMC, 24-hour health advice and physician referrals: (443) 481-4000
Home | Search | Directions | Phone Directory | Info for Patients & Visitors | Contact Us


Anne Arundel Medical Center

Anne Arundel Medical Center is a private non-profit hospital serving Maryland.

Anne Arundel Medical Center is an Equal Opportunity Employer and an Equal Opportunity Health Care Provider.

2001 Medical Parkway, Annapolis Maryland 21401
(443) 481-1000 | TDD: 443-481-1235
www.askAAMC.org